Rapid Micro Biosystems (RPID) Revenue Growth (3y) (2023 - 2026)

Rapid Micro Biosystems (RPID) Revenue Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 4.63%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 8.01%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 5.28%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 15.36%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 10.52%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 2.92%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.73%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 17.14%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 7.43%
10 Rapid Micro Biosystems 80.19 Mn 57.24 Mn 371,000.00 16.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 16.70%
Dec 31, 2025 37.14%
Sep 30, 2025 18.26%
Jun 30, 2025 23.45%
Mar 31, 2025 20.09%
Dec 31, 2024 16.42%
Sep 30, 2024 3.30%
Jun 30, 2024 2.59%
Mar 31, 2024 3.95%
Dec 31, 2023 6.55%
Sep 30, 2023 5.41%
Jun 30, 2023 24.48%